In addition, a prolonged antigen release from particulate vaccines resulted in enhanced antigen presentation, an increased number of cytotoxic CD8+ T cells, and thus, increased anti-tumor immunity in vivo [10]. The gene discussed is CD8A; the disease is neoplasm.